Current thrombolytic agents generally possess low specificity and pose a high risk of intracranial hemorrhage. Here, various generations of multiarm polylactic acid–polyglutamic acid peptide dendri... Click to show full abstract
Current thrombolytic agents generally possess low specificity and pose a high risk of intracranial hemorrhage. Here, various generations of multiarm polylactic acid–polyglutamic acid peptide dendri...
               
Click one of the above tabs to view related content.